The Cooper Companies, Inc.

NASDAQ:COO

Medical - Instruments & Supplies

Healthcare
$60.75 -3.42%

-$2.30 today

Market cap
$11.55B
Beta
0.87
P/E (TTM)
53.8
EPS (TTM)
$1.21
52W Low $58.89High $89.83

Volume 2.20M

Average 2.55M

COO Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

The Cooper Companies, Inc.NASDAQ: COO

Research & Development · Q3 FY2026 · quarter ended Jul 2026

Research & development dips below year-ago levels

Q3 FY2026 research & development of $41.6M fell 6.7% year over year, behind the +0.8% change in trailing-twelve-month research & development. Sequentially, it fell 2.1% from the prior quarter. Over 3 fiscal years it compounded at +16.0% a year.

Context

  • Research & development amounted to 4.2% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Research & development increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -6.7% toward the trailing-twelve-month pace of +0.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJul 2026
$41.6M-2.1% QoQ
Last fiscal yearOct 2025
$172.2M+11.0% YoY
LTMJul 2026
$169.8M+0.8% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-6.7%——
1 year+11.0%——
3-year CAGR+16.0%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
172.2M USD
Year-over-year change
+11.0%
4-year CAGR
+16.7%

Research & Development vs competitors

How COO compares with its peers on the latest reported figures

  • COO's LTM Jul 2026 research & development of $169.8M is the 4th highest of the 6 companies compared; the peer median is $177.17M.
  • Its year-over-year change of +0.8% is the 5th highest of 6, against a peer median of +12.5%.
  • Research & development amounts to 4.0% of revenue for COO, versus a peer median of 13.1%.
COO Competitors Peer median
Research & Development for COO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$1.44B +51.4%+12.1%13.1%
BLCOBausch + Lomb CorporationLTM Jun 2026$404M +12.5%+6.5%7.6%
GKOSGlaukos CorporationLTM Jun 2026$177.17M +26.4%+6.9%28.9%
COOThe Cooper Companies, Inc.LTM Jul 2026$169.8M +0.8%+16.0%4.0%
STAASTAAR Surgical CompanyLTM Apr 2026$38.43M -26.2%+3.6%13.2%
LNSRLENSAR, Inc.LTM Mar 2026$5.47M +1.0%-21.9%9.5%
Peer median (excluding COO) $177.17M+12.5%+6.5%13.1%

Competitors are the stored peer set for COO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Revenue2.92B3.31B3.59B3.9B4.09B
Cost of Revenue966.7M1.17B1.24B1.3B1.61B
Gross Profit1.96B2.14B2.36B2.6B2.48B
Gross Margin66.9%64.7%65.6%66.6%60.7%
Research & Development92.7M110.3M137.4M155.1M172.2M
Selling, General & Admin1.21B1.34B1.5B1.53B1.63B
Operating Expenses1.45B1.63B1.82B1.89B1.8B
Depreciation & Amortization309.3M346.1M367.7M375.1M423M
EBITDA823.9M878.7M885.9M1.07B1.05B
EBITDA Margin28.2%26.6%24.7%27.5%25.7%
Operating Income505.8M507.6M533.1M705.7M682.9M
Operating Margin17.3%15.3%14.8%18.1%16.7%
Interest Income00000
Interest Expense23.1M57.3M105.3M114.3M100M
Other Income / Expenses(14.3M)(32.3M)(120.2M)(123.4M)(116.4M)
Income Before Tax491.5M475.3M412.9M582.3M566.5M
Pre-Tax Margin16.8%14.4%11.5%14.9%13.8%
Income Tax Expense(2.45B)89.5M118.7M190M191.6M
Net Income2.94B385.8M294.2M392.3M374.9M
Net Margin100.8%11.7%8.2%10.1%9.2%
EPS (Basic)14.931.961.491.971.88
EPS (Diluted)14.791.941.481.961.87
Weighted Avg Shares197.2M197.2M198M198.9M200M
Weighted Avg Shares (Diluted)199.4M198.8M199.2M200.4M200M

The Cooper Companies, Inc.

NASDAQ:COO

Intrinsic Alpha fair value

Locked

Current Price

$60.75

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.